Target intelligence / Profile preview

Cysteine-rich secretory protein (CRISP)

Target
CRISP
Molecular classification
Cysteine-rich secretory protein family, CAP superfamily, Toxin
01

Overview

Cysteine-rich secretory proteins (CRISPs) are a significant class of non-enzymatic toxins found in the venom of the Eastern Russell's viper, Daboia siamensis (formerly classified as Daboia russelii siamensis). These proteins are characterized by a highly conserved arrangement of sixteen cysteine residues that form eight disulfide bridges, providing a stable molecular framework within the CAP (CRISP, Antigen 5, and PR-1) superfamily (UniProt, 2023). Biologically, CRISPs from this species function primarily as ion channel modulators, specifically targeting voltage-gated calcium channels and cyclic nucleotide-gated channels, which can lead to the inhibition of smooth muscle contraction and disruption of normal physiological signaling (PubMed, 2015). While they are generally less lethal than the phospholipases A2 or snake venom metalloproteinases found in the same venom, they contribute to the overall complexity and synergistic toxicity of the envenomation (Journal of Proteomics, 2015). In a clinical context, these proteins are the targets of antivenom therapy, where specific polyclonal antibodies bind and neutralize the toxins to prevent further systemic damage. Research into these proteins also explores their potential as molecular scaffolds for drug design due to their high specificity for various ion channels (Toxins, 2012).

Other names
Daboia russelii siamensis CRISPRussell's viper CRISPCAP proteinDaboia siamensis CRISPCysteine-rich secretory protein 1
02

Mechanism of action

Neutralization of toxin activity via antibody binding

03

Biological functions

Ion channel blockadeInhibition of smooth muscle contractionVoltage-gated calcium channel modulationCyclic nucleotide-gated channel inhibitionPotassium channel regulation
04

Disease associations

Snake envenomation
05

Safety considerations

Antivenom-induced anaphylaxisSerum sicknessCross-reactivity with other venom components
06

Interacting drugs

Russell's viper antivenom

1 more in the full profile.

07

Biomarkers

Venom antigen levelsSerum venom concentration

Beyond the preview

Go deeper on Cysteine-rich secretory protein (CRISP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine-rich secretory protein (CRISP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call